AstraZeneca COVID-19 vaccine linked to ‘very small’ increased risk of bleeding, study says

931945

Sumary of AstraZeneca COVID-19 vaccine linked to ‘very small’ increased risk of bleeding, study says:

  • While the AstraZeneca COVID-19 vaccine is not yet authorized for use in the U.S., an independent committee advising vaccinations in the U.K..
  • Researchers also found an incidence of 1.13 cases per 100,000 of so-called idiopathic thrombocytopenic purpura (ITP), or a blood disorder involving an abnormal drop in the number of platelets, per Hopkins Medicine..
  • researchers noted ITP during AstraZeneca’s post-vaccination period for 40–49-year-olds 0.62 more events than expected per 100,000 doses, and in the adults under study, there were 0.46 more events than expected per 100,000 doses..
  • Researchers noted three deaths post-ITP, though not due to ITP, and the deaths occurred in both vaccinated and unvaccinated people over age 70..
  • “First dose of ChAdOx1 was found to be associated with small increased risks of ITP, with suggestive evidence of an increased risk of arterial thromboembolic and hemorrhagic events….

Want to know more click here go to source.

From -
Close
Generic selectors
Exact matches only
Search in title
Search in content

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close